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Background: The prevalence of HIV in specific areas of South Africa and its impact on 
haematological parameters are largely unknown.
Objectives: To (1) describe the prevalence of HIV, (2) stage HIV based on CD4 counts, and (3) 
determine haematological parameters amongst participants in Mangaung, Free State Province.
Method:  Blood  specimens  were  obtained  from  419  participants  in  formal  and  informal 
settlements in Mangaung. Participants were 25–64 years of age; 23.4% were male. Males and 
females were a mean of 45.1 and 44.3 years of age, respectively. Screening for HIV status was 
performed. Positive results were confirmed by a second test. Full blood counts were performed 
on all participants, and CD4 counts only on HIV-positive serum.
Results: The overall prevalence of HIV was 40.8%. The highest prevalence occurred in the 
31–40 years age group, with 38.4% of females and 39.5% of males being infected. More than 
33% of HIV-uninfected participants were 51–60 years of age. No significant change in CD4 
count with age was observed, probably because 19.1% of the 225 respondents who reported 
using  medication  were  receiving  antiretroviral  (ARV)  treatment.  Haematological  results 
showed that HIV-infected participants had significantly reduced values for haemoglobin, 
leukocytes,  neutrophils  and  lymphocytes,  compared  to  HIV-uninfected  participants.  The 
mean corpuscular volume (MCV) was significantly higher in HIV-infected participants.
Conclusions: A high prevalence of HIV-infection was found. Anaemia and significantly 
reduced white blood cell counts were observed in the HIV-infected group. No significant 
change in CD4 counts with age was observed and could possibly be attributed to ARV therapy.
© 2012. The Authors.
Licensee: AOSIS 
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Attribution License.
Page 1 of 5
Staging et anomalies hématologiques chez des personnes séropositives à Mangaung dans la 
province de l’État libre, Afrique du Sud
Contexte: La prévalence du VIH dans des zones spécifiques d’Afrique du Sud et son impact 
sur les paramètres hématologiques sont pour l’essentiel inconnus. 
Objectifs: (1) Déterminer la prévalence du VIH, (2) le stade de progression du VIH sur la 
base de la numération des CD4  et (3) les paramètres hématologiques chez des participants à 
Mangaung, province de l’État libre.
Méthode: Des échantillons sanguins ont été obtenus auprès de 419 participants dans des zones 
d’habitation formelles et informelles à Mangaung. Les participants étaient âgés de 25 à 64 ans 
et 23.4% étaient de sexe masculin. L’âge moyen des hommes et des femmes était de 45.1 er 44.3 
ans respectivement. Un dépistage afin d’établir le statut VIH a été réalisé. Les résultats positifs 
ont été confirmés par un deuxième test. Une numération globulaire complète a été réalisée 
sur tous les participants, et une numération de CD4 uniquement sur les sérums diagnostiqués 
positifs pour le VIH.
Résultats: La prévalence générale du VIH était de 40.8%. La prévalence la plus élevée s’est 
produite dans la tranche d’âge des 31 à 40 ans, 38.4% des femmes et 39.5% des hommes étant 
infectés. Plus de 33% des participants séronégatifs appartenaient à la tranche d’âge des 51 à 60 
ans. Aucun changement significatif en termes de numération des CD4 en fonction de l’âge n’a 
été observé, probablement en raison du fait que 19.1% des 225 sondés ayant déclaré prendre des 
médicaments bénéficiaient d’un traitement antirétroviral (ARV). Les résultats hématologiques 
ont indiqué que les participants séropositifs présentaient des taux significativement réduits 
d’hémoglobines, de leucocytes, de neutrophiles et de lymphocytes, par rapport aux participants 
séronégatifs. Le volume globulaire moyen (VGM) était significativement plus élevé chez les 
participants séropositifs. 
Conclusions: Une prévalence élevée de l’infection par le VIH a été constatée. Une anémie et 
un nombre de globules blancs significativement réduit ont été observés dans le groupe des 
participants séropositifs. Aucun changement significatif en termes de numération des CD4 en 
fonction de l’âge n’a été observé, ce qui pourrait probablement être attribué à la thérapie ARV. Original Research
doi:10.4102/phcfm.v4i1.462 http://www.phcfm.org
Introduction
Key focus
According to a national community-based survey conducted 
in South Africa in 2004, the prevalence of HIV in the general 
population at that time was 11.4%.1 In 2006, the prevalence 
of  HIV  infection  amongst  antenatal  clinic  attendees  varied 
between 15.1% in the Western Cape and 39.1% in KwaZulu-
Natal. At that time, the Free State Province had a reported 
prevalence of 31.1%, whilst the national prevalence was 29.1%.2
Staging  is  used  to  classify  patients  living  with  HIV  and 
patients that have AIDS into groups with different prognoses. 
The Centres for Disease Control and Prevention (CDC)3 uses 
CD4 counts of > 500 cells per mm3, 200–499 cells per mm3 
and < 200 cells permm3 to determine clinical and therapeutic 
management of HIV-positive adolescents and adults. A 
CD4 count of < 200 cells permm3 is regarded as indicative of 
progression towards full-blown AIDS.3
A routine full blood count can be valuable as part of the 
general investigation of an acute illness, regular monitoring 
of HIV infection, or monitoring of the side-effects of certain 
drug  treatment  regimens  such  as  Zidovudine  (AZT).4 
Haematological abnormalities may give an indication of 
impaired  oxygen-carrying  capacity,  risk  of  infections  and 
bleeding tendencies.4
Aim of the study
This investigation formed part of the Assuring Health for 
All in the Free State (AHA FS) research project, a prospective 
epidemiological study with the main aim to determine how 
living in rural and urban areas affects lifestyle and indicators 
of  health.  A  multidisciplinary  research  team  investigated 
socio-demographic status; household food security; dietary 
intake; levels of physical activity; knowledge, attitudes and 
practices  related  to  nutrition;  and  reported  health  status, 
using standardised questionnaires. In addition to a medical 
examination,  anthropometric  measurements  and  blood 
specimens were also obtained for various investigations. A 
rural baseline study was completed in 2007,5 whilst the urban 
baseline study was conducted in Mangaung in the Motheo 
District of the Free State province during 2009.
The aim of this particular component of the study was to, (1)   
describe the prevalence of HIV, (2) stage HIV by means of CD4 
counts, and (3) determine haematological differences between 
HIV-uninfected  and  HIV-infected  participants  in  urban 
Mangaung, and to compare the findings with data obtained 
from the rural settlements previously investigated.5
Significance
We  determined  the  prevalence  of  HIV  infection  in  an 
urban area in the Free State Province, staged HIV-infected 
participants  into  different  CD4  count  categories,  and 
measured the extent of haematological abnormalities in 
all participants.
Ethical considerations
Approval to conduct the study was obtained from the Ethics 
Committee of the Faculty of Health Sciences at the University 
of the Free State in Bloemfontein (ETOVS nr: 21/07), the 
provincial  Department  of  Health  and  local  municipalities. 
Before  onset  of  the  study,  all  selected  households  were 
visited by trained fieldworkers and written informed consent 
to  participate  was  obtained  in  the  language  of  choice. 
Participation was voluntary and participants could withdraw 
at any time. All information was treated as strictly confidential. 
Pre- and post-intervention counseling was provided by 
medical practitioners. After completion of the urban baseline 
study  and  according  to  their  clinical  findings,  participants 
who required medical services for management and follow-up 
were referred to the appropriate local or provincial facilities.
Methods
Setting
The urban baseline study was performed over a ten-day period 
in March 2009. Fasting venous blood samples were obtained 
from participants from 391 black households (n = 419), living in 
formal and informal settlements in Mangaung, Bloemfontein. 
Sampling and design
The number of plots in the Mangaung University Community 
Partnership Programme (MUCPP) service area was counted 
on a municipal map and included Buffer, Freedom Square, 
Kagisanong,  Chris  Hani,  Namibia  and  Turflaagte.  An 
estimate was made of additional squatter households in 
open areas. A stratified proportional cluster sample was 
selected, stratified by area and formal plot and/or squatter 
households in open areas. Using randomly selected X and 
Y  coordinates,  100  starting  points  were  selected  in  this 
way.  This  sample  was  considered  representative  of  the 
population served by the MUCPP clinic and results are 
indicative of the extent of the problem in this area. From 
each starting point, five adjacent starting households were 
approached. All volunteers between the ages of 25 and 64 
years were eligible to participate. With the exception of age, 
the only requirement for inclusion in the study was written 
informed consent.
Procedure
Final-year and postgraduate students from the Department 
of Nutrition and Dietetics at the University of the Free State 
(UFS) conducted the interviews to complete household socio-
demographic and individual health questionnaires. The 
interviews were performed under supervision of lecturers as 
part of the Service Learning function of the University.
Medical examinations were performed at the MUCCP clinic 
by medical doctors from the Department of Basic Medical 
Sciences,  Faculty  of  Health  Sciences,  UFS.  It  is  possible 
that participants with an existing medical problem were 
more likely to participate in the study, whilst bed-ridden 
participants could have found it difficult to visit the research 
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venue to participate. More women than men participated in 
the study, most probably because more men are employed. 
Due to these reasons, the authors acknowledge that the study 
group is probably not representative of the general population.
All participants were screened for HIV using two fourth-
generation serum assays. Primary screening for HIV status 
was performed using the Enzygnost HIV Integral II Ag/
Ab test (Dade Behring; Marburg, Germany). Positive cases 
were confirmed by the Vironostica HIV Uni-Form II Ag/
Ab test (bioMérieux; Boxtel, The Netherlands). Serum CD4 
counts were measured with an Epics XL flow cytometer 
(Beckman Coulter; Atlanta, GA, USA). Full blood counts 
were obtained from blood collected in EDTA-containing 
tubes, using a Sysmex XT 2000i analyser (Roche Diagnostics; 
Indianapolis, IN, USA).
Analysing
Descriptive statistics were used to report findings, and the 
t-test to measure the significance of differences (p ≤ 0.05) 
between HIV-infected and -uninfected groups.
Results
Blood specimens were obtained from 419 participants in 
formal and informal settlements in Mangaung. Participants 
between 25 and 64 years of age were included in the study, 
of which 23.4% were male (mean age 45.1 years) and 76.6% 
female (mean age 44.3 years). 
Of the 225 respondents who reported using medication, 43 
(19.1%)  indicated  that  they  were  receiving  antiretroviral 
(ARV) treatment at the time of the study.
The overall prevalence of HIV infection in this survey was 
40.8%, with 41.7% of female and 38.5% of male participants 
being infected. The peak prevalence of HIV occurred in the 
31–40 years age group, with 38.4% of females and 39.5% of 
males in this age group being HIV-infected.
The distribution of CD4 counts, performed only on HIV-
infected participants, showed that 22.2%, 42.1% and 35.7% 
of  participants  had  CD4  counts  above  500  cells/mm3, 
between 200 and 499 cells/mm3, and below 200 cells/mm3, 
respectively.
The age distribution of HIV-uninfected and HIV-infected 
participants and the distribution of mean CD4 counts in 
relation to age (Figure 1). Participants were grouped in 10-year 
intervals. The majority (38.6%) of HIV-infected participants 
were 31–40 years of age, whilst HIV-uninfected individuals 
were mostly represented in the 51–60 years age group (36.3%). 
No significant change in CD4 count with age was observed.
Haematological results showed that HIV-infected participants 
had  significantly  reduced  haemoglobin  (in  both  males 
and females p < 0.0001), leukocyte (p < 0.0001), neutrophil 
(p < 0.0001) and lymphocyte values (p < 0.0001) compared to 
HIV-uninfected participants. The mean corpuscular volume 
(MCV) was significantly higher (p < 0.001) in HIV-infected 
participants. No significant difference was observed between 
the two groups with regard to the platelet count. Results of 
haematological investigations are presented (Table 1).
Discussion
The Mangaung area consists of both formal and informal 
settlements. The prevalence of HIV infection (40.8%) confirms 
a recent finding6 in which 60% of women aged 25–34 years 
and 38% of women aged 35–44 years were found to be HIV-
positive. This prevalence of HIV in the Mangaung area is 
much  higher  than  the  observed  17.1%  amongst  participants 
in  rural  the  Free  State,  which  included  Springfontein, 
Trompsburg, and Philippolis.5
TABLE 1: Haematological findings in HIV-infected and HIV-uninfected participants in Rural‡ and urban areas of the Free State.
Haematological variables
 
Normal 
range†
 
Rural‡ Urban
Mean HIV-
negative
n = 458 Mean HIV-
positive
n = 94 p Mean HIV-
negative
 n = 248 Mean HIV-
positive
n = 171 p
Male Haemoglobin (g/dL) 14.3–18.3 15.3 1.3 14.4 1.7 < 0.01 15.2 1.5 13.7 2.1 < 0.0001
Female Haemoglobin (g/dL) 12.3–16.3 13.9 1.3 13 1.3 < 0.0001 13.5 1.2 12.4 1.8 < 0.0001
White blood cell count (x 109 cells/L) 4–10 7.4 2.2 6.5 2.6 < 0.001 6.5 2.0 5.4 1.8 < 0.0001
Mean corpuscular volume (fL) 80–100 94.3 6.7 93.6 7.2 > 0.05 91.2 6.2 93.9 8.4 < 0.001
Platelet count (x 109 cells/L) 137–373 278.6 74.0 269.2 72 > 0.05 279.4 81.0 267 88.0 > 0.05
Neutrophil count (x 109 cells/L) 2–7.5 4.0 1.8 3.4 2.1 < 0.01 3.5 1.6 2.8 1.3 < 0.0001
Lymphocyte count (x 109 cells/L) 1–4 2.7 0.9 2.4 1.1 < 0.01 2.4 0.8 2.0 0.8 < 0.0001
n, Given as number; p, significant value.
†, Normal ranges used by the laboratories of the South African National Health Laboratory Service (NHLS).
‡, Information obtained from the following article: Groenewald AJ, Van Wyk HJ, Van Zyl S, Van der Merwe LJ, Walsh CM. Staging and haematological abnormalities of HIV-infected persons in the 
rural Free State Province of South Africa. Afr J Prim Health Care Fam Med. 2011;3(1). http://dx.doi.org/10.4102/phcfm.v3i1.222
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FIGURE 1: Distribution of HIV infection and mean CD4 counts according to age 
groups in urban Mangaung.Original Research
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Nationally, HIV prevalence peaks in women aged 20–29 years 
(24.1%) and in men aged 30–39 years (21.3%).1 In a rural 
study,5 it was observed that HIV prevalence peaked later 
at 31–40 years (41.3%) in women and 41–50 years (37.9%) in 
men. The observation that peak prevalence of HIV infection 
in women occurs at a younger age than in men could reflect 
the fact that men tend to have sexual partners younger than 
themselves.7 In the present (urban) study, HIV prevalence 
in both females (38.4%) and males (39.5%) peaked at 31–40 
years. This high urban prevalence of HIV where men peaked 
earlier and at the same time as women may be due to the 
effect of lifestyle transitions that occur when people move 
from rural to urban areas. 
CD4 count and viral load tests are essential parts of the 
monitoring of both the course of HIV infection over time 
as well as the patient’s response to treatment.8 CD4 counts 
greater than 500 cells/mm3 are associated with a healthy 
immune system, which weakens with progression of HIV 
infection until levels lower than 200 cells/mm3 are reached.3 
Low CD4 counts are associated with a compromised immune 
system, serious infections and general health problems. In a 
recent rural study,5 the peak prevalence of HIV infection in the 
age group 31–40 years supported the significantly low mean 
CD4 count (276 cells/mm3) in the age group 41–50 years. This 
finding suggests that from the onset of infection with the virus 
until progression into AIDS, takes approximately ten years.9 
In the present study, the prevalence of HIV also peaked at 
31–40 years (Figure 1). Although not statistically significant, 
CD4 counts were generally much lower in the urban (mean 
± s.d. = 346 ± 251 cells/mm3) than in the rural5 (mean ± s.d. 
= 399 ± 270 cells/mm3) participants. No significant change 
with age was observed, probably because a large number of 
participants received antiretroviral (ARV) treatment.
Antiretroviral treatment may cause macrocytosis10 and may 
be the reason why the mean corpuscular volume of HIV-
infected participants in this urban study was significantly 
higher than in uninfected participants (p > 0.001, Table 1). 
In the rural study, the mean corpuscular volume remained 
unchanged,  as  none  of  the  participants  received  ARV 
treatment.5 
Differences in the rest of the haematological parameters 
between HIV-infected and -uninfected individuals (Table 1) 
were in general more pronounced in urban participants 
than  found  in  a  recent  rural  study.5  Haemoglobin  was 
significantly reduced in HIV-infected males (p < 0.0001) and 
females (p < 0.0001) compared to uninfected participants 
(Table 1). Anaemia could contribute to symptoms of fatigue 
and breathlessness. It is more common amongst people 
with  HIV  infection  and  may  be  caused  by  HIV  itself, 
opportunistic  infections  or  treatment.4  The  significantly 
reduced haemoglobin values found in HIV-uninfected males 
are probably indicative of a generally ill study population. 
Total as well as differential white cell counts were determined 
for each participant (Table 1). Compared to HIV-uninfected 
participants, significantly reduced white blood cell (p < 0.0001) 
and neutrophil counts (p < 0.0001) might enhance the risk 
of bacterial and fungal infections.4 Significantly reduced 
lymphocyte counts (p < 0.0001) observed in our study, may 
be associated with HIV-related infection and killing of CD4 
T-cells.8 Lymphocyte counts between 1.0 and 2.0 x 109 cells/L 
were found to be a significant predictor of CD4 < 200 cells 
mm-3.11 Our mean (± s.d.) lymphocyte count for participants 
with  CD4  <  200  cells/mm3  was  1.45  (±  0.66)  in  urban 
participants. Lymphocyte count may therefore serve as a 
useful predictive tool in the management and monitoring 
of  HIV-infected  patients  in  resource-limited  settings.11 
The impact of HIV-infection on haematological changes is 
reversible by highly active anti-retroviral therapy (HAART).12
Limitations of the study
A possible limitation of the study could be that participants 
with a specific medical problem were more likely to participate 
in the study. More women than men participated in the study, 
most probably because more men were employed. Due to 
these factors, we acknowledge that the study group was 
probably not representative of the general population.
Recommendations
Only  19.1%  of  HIV-infected  participants  indicated  that 
they were receiving ARV treatment. Yet, 35.7% of HIV-
infected participants had a CD4 count below 200 cells/
mm3. ARV treatment for more participants would thus 
seem justified and is recommended.
Conclusion
The prevalence of HIV in urban Mangaung was higher 
compared to the rural Free State. A high prevalence of anaemia 
and significantly reduced white blood cell and neutrophil 
counts were observed in HIV-infected participants. The CD4 
counts were in general much lower than in the rural study.5 
No significant change in CD4 counts with age was observed, 
probably because a large number of participants received 
ARV treatment. The latter may also cause macrocytosis,10 
possibly reflected by the mean corpuscular volume being 
significantly larger in HIV-infected participants. All these 
changes are probably the result of a change in lifestyle and 
ARV treatment.
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